Comparison of Anti-mullerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome

Creative Commons License

Ozay A. C., Ozay O. E., GÜLEKLİ B.

GINEKOLOGIA POLSKA, cilt.91, sa.11, ss.661-667, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 91 Sayı: 11
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5603/gp.a2020.0122
  • Dergi Adı: GINEKOLOGIA POLSKA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Gender Studies Database, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.661-667
  • Anahtar Kelimeler: polycystic ovary syndrome, phenotype, polycystic ovarian morphology, anti mullerian hormone, hyperandrogenism, LATE REPRODUCTIVE-AGE, INSULIN-RESISTANCE, SERUM AMH, WOMEN, CRITERIA, EXCESS, PCOS, ANDROGEN, OBESITY, LEVEL
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objectives: The aim is to compare the hormonal status and anti-mullerian hormone (AMH) levels of patients who have different polycystic ovary syndrome (PCOS) phenotypes, polycystic ovarian morphology (PCOM) and healthy women.